OBSTETRICS & GYNECOLOGY
Hypertensive Disorders in Pregnancy 214 practice questions · 111 study notes
Start chapter practice
Questions QUESTION 41
A pregnant patient develops sudden, generalized edema. Which complication may this indicate?
QUESTION 42
When assessing severe blood pressure elevation as a severe feature of PE or GH, what minimum interval is specified between the two measurements while the patient is on bed rest?
QUESTION 43
During urine monitoring, protein is detected on daily examination. Over what collection period should its amount be estimated?
QUESTION 44
Which combination constitutes the lytic cocktail listed among alternative anticonvulsant regimens?
QUESTION 45
Which trend in urinary output and proteinuria is a favorable sign during monitoring?
QUESTION 46
Which effect on recurrent convulsions is listed as a benefit of magnesium sulfate compared with other regimens?
QUESTION 47
Which 24-hour urinary output is described as very ominous?
QUESTION 48
How do the histopathological and biochemical changes of eclampsia compare with those of pre-eclampsia?
QUESTION 49
Which combination is described for managing heart failure complicating eclampsia?
QUESTION 50
What is the therapeutic serum magnesium range?
QUESTION 51
What oxytocin regimen is specified immediately following delivery in the management of eclampsia?
QUESTION 52
A pregnant woman continues to have eclamptic fits despite anticonvulsant treatment for 6–8 hours. What is the recommended next step?
QUESTION 53
Why should excess dextrose or crystalline solutions be avoided in pre-eclampsia–eclampsia despite hypovolemia?
QUESTION 54
At what rate should balanced salt solution be infused during fluid management of pre-eclampsia–eclampsia?
QUESTION 55
Below what gestational age is steroid therapy specified in the management of pregnancy complicated by eclampsia?
QUESTION 56
A woman with pre-eclampsia has severe hypertension and reduced urine output. Which monitoring measure is specifically indicated in this situation?
QUESTION 57
Which pregnancy condition is specifically associated with the rare occurrence of eclamptic convulsions in the early months?
QUESTION 58
Which intravenous regimen is described for reducing pulmonary edema and preventing adult respiratory distress syndrome in eclampsia?
QUESTION 59
A woman receiving magnesium develops severe cardiac toxicity related to hypermagnesemia. Which antidote should be administered?
QUESTION 60
How does the frequency of eclampsia in twin pregnancies compare with that in singleton pregnancies?
QUESTION 61
Excessive release of which excitatory neurotransmitter is implicated in eclamptic convulsions?
QUESTION 62
Which finding is a stated reason to monitor serum magnesium levels during magnesium therapy?
QUESTION 63
In severe pre-eclampsia, the normal retinal vein-to-arteriole diameter ratio of 3:2 may change to which ratio?
QUESTION 64
A pregnant woman reports ankle swelling that remains when she gets out of bed in the morning and increasing tightness of her finger ring. In pre-eclampsia, what do these findings represent?
QUESTION 65
When do symptoms usually appear in the course of pre-eclampsia?
QUESTION 66
What hemodynamic pattern characterizes spiral arterioles after their physiological transformation in pregnancy?
QUESTION 67
Which substance liberated from the placenta destroys angiotensin-II in normal pregnancy?
QUESTION 68
Regular antenatal checkups for primary prevention specifically seek early detection of a rising trend in which blood pressure component?
QUESTION 69
Which abnormality of trophoblast migration is associated with reduced blood supply to the fetoplacental unit in pre-eclampsia?
QUESTION 70
A pregnant patient admitted for pre-eclampsia is resting in bed. Which position is recommended to lessen vena caval compression?
QUESTION 71
Which physiological effect of rest accounts for increased diuresis during hospital management of pre-eclampsia?
QUESTION 72
At what gestational age do endovascular trophoblasts invade up to the decidual segments during the first trimester?
QUESTION 73
Which feature of pre-eclampsia is described as the last to appear?
QUESTION 74
Which vessels are normally invaded by endovascular trophoblasts in the uteroplacental bed?
QUESTION 75
What is the minimum total protein excretion in a 24-hour urine collection considered significant proteinuria in pregnancy?
QUESTION 76
Which auscultatory event is used to record diastolic blood pressure in pregnancy?
QUESTION 77
A woman with pre-eclampsia requires induction of labor and has a ripe cervix. Which induction method is described as the method of choice?
QUESTION 78
Beyond which blood pressure level does the text recommend labetalol, nifedipine or hydralazine to prevent target organ damage in hypertensive pregnancy?
QUESTION 79
What is the stated overall risk of superimposed pre-eclampsia in women with chronic hypertensive disease?
QUESTION 80
Why is routine antihypertensive drug use not favored in the management described for hypertensive pregnancy?
Study notes Clinical significance of hypertension in pregnancy
Hypertension is a common medical complication of pregnancy with consequences for both mother and baby. →
Pre-eclampsia and related hypertensive disorders of pregnancy
Pre-eclampsia is a progressive multisystem disorder involving new hypertension with proteinuria or other evidence of end-organ dysfunction. →
Blood pressure, edema and proteinuria criteria in pregnancy
The passage describes blood pressure thresholds and measurement technique, along with edema and proteinuria findings relevant to pre-eclampsia. →
Urine dipstick protein grading and hospital incidence of pre-eclampsia
Multiple reagent strips provide semiquantitative urine protein grades corresponding to the concentrations listed below. →
Pathogenesis of hypertension in pre-eclampsia
The passage links abnormal placentation to widespread vascular dysfunction underlying hypertension. →
Trophoblast invasion of uteroplacental spiral arterioles
Normal placentation involves endovascular trophoblast invasion into the walls of spiral arterioles in the uteroplacental bed. →
Normal trophoblast invasion and spiral arteriole remodeling
Normal endovascular trophoblast invasion remodels the spiral arterioles of the uteroplacental bed. →
Uteroplacental vascular adaptation and its failure in pre-eclampsia
Normal pregnancy involves changes in spiral arteriolar blood flow and vascular responsiveness that help stabilize blood pressure. →
Vascular endothelial growth factor and uteroplacental blood flow
Vascular endothelial growth factor (VEGF) contributes to the regulation of uteroplacental blood flow in pregnancy. →
Prostaglandin imbalance in pre-eclampsia
Pre-eclampsia is associated with an imbalance between vasodilator prostaglandin and vasoconstrictor thromboxane. →
Vascular sensitivity and nitric oxide synthesis
The discussion of pre-eclampsia describes altered sensitivity to a pressor agent and identifies the sites and substrate of nitric oxide synthesis. →
Endothelial and placental mechanisms in pre-eclampsia
Vascular mediators, inflammation and placental hypoxia contribute to hypertension and endothelial dysfunction. →
Endothelial dysfunction and organ effects in pre-eclampsia
Pre-eclampsia involves vasoconstriction, endothelial dysfunction and disturbances of organ perfusion. →
Trophoblastic antiangiogenic factors in pre-eclampsia
Pre-eclampsia is associated with an imbalance of angiogenic and antiangiogenic proteins in the placental vascular bed. →
Antiangiogenic effects and factor V Leiden in pre-eclampsia
The passage continues the discussion of factors implicated in pre-eclampsia. →
Endothelial dysfunction, vasospasm and edema in pre-eclampsia
Pre-eclampsia is characterized by endothelial dysfunction and vasospasm. The passage describes contributing mechanisms and probable explanations for edema. →
Mechanism and protein composition of proteinuria in pre-eclampsia
The proposed mechanism of proteinuria combines glomerular endothelial injury with depressed tubular reabsorption. →
Placental changes in pre-eclampsia and eclampsia
Pathological changes associated with organ dysfunction are well documented, especially in severe pre-eclampsia or eclampsia, although why the syndrome occurs remains unresolved. →
Placental, renal, vascular and hepatic changes in pre-eclampsia
Pre-eclampsia and eclampsia produce pathological changes in the uteroplacental circulation and several maternal organs. →
HELLP syndrome: presentation, management and complications
HELLP syndrome is a complication of pre-eclampsia that may occur even without maternal hypertension. →
Cerebral involvement, PRES and cardiopulmonary changes
The passage describes neurological and cardiopulmonary involvement in hypertensive disorders of pregnancy, including posterior reversible encephalopathy syndrome (PRES). →
Fluid redistribution and hematological changes in pre-eclampsia
Pre-eclampsia combines salt retention and extravascular fluid accumulation with intravascular volume contraction and hematological abnormalities. →
Biochemical, hormonal and oxidative changes in pre-eclampsia
The passage links laboratory abnormalities to disease severity, renal involvement and endothelial damage in pre-eclampsia. →
Severe features in pre-eclampsia or gestational hypertension
This passage introduces the severe-feature category of pre-eclampsia or gestational hypertension and begins its blood pressure criterion. →
Neurological, hepatic, platelet and renal severe features
These abnormalities are listed among the severe features of pre-eclampsia or gestational hypertension. →
Pulmonary edema and hypertension without severe features
The passage describes the mechanism of pulmonary edema and the blood pressure profile listed for pre-eclampsia or gestational hypertension without severe features. →
Onset and course of the hypertensive syndrome in pregnancy
The passage contrasts the usual onset and progression of the syndrome with its rare acute presentation. →
Symptom onset and early edema in pre-eclampsia
Pre-eclampsia is principally a syndrome of signs; symptoms usually appear late. →
Alarming symptoms of pre-eclampsia
Severe symptoms may occur singly or together and are usually associated with acute onset of the syndrome. →
Abnormal weight gain as a sign of pre-eclampsia
Rapid changes in maternal weight may precede visible fluid accumulation in pre-eclampsia. →
Clinical signs and progression of pre-eclampsia
Pre-eclampsia may manifest through rapid weight gain, hypertension, edema, and evidence of placental or systemic involvement. →
Severe pre-eclampsia as a multisystem disorder
Severe pre-eclampsia involves several organ systems, as shown by its hematological, renal, hepatic, pulmonary and neurological manifestations. →
Urinary and retinal findings in pre-eclampsia
The investigations described for pre-eclampsia include assessment of proteinuria and ophthalmoscopic examination for retinal changes. →
Laboratory evaluation, fetal monitoring and progression of pre-eclampsia
Assessment of pre-eclampsia includes maternal blood investigations and fetal wellbeing surveillance because widespread organ dysfunction may progress to end organ damage. →
Course of pre-eclampsia after early treatment
Early detection and prompt, effective treatment may stabilize the features of pre-eclampsia. →
Progression of pre-eclampsia and occurrence of eclampsia
The passage describes worsening pre-eclamptic features and circumstances in which eclampsia may occur. →
Immediate maternal and fetal complications of pre-eclampsia
Complications are more likely when pre-eclampsia is untreated. Maternal complications vary across pregnancy, labor, and the puerperium. →
Long-term health outcomes after severe pre-eclampsia
Severe pre-eclampsia is associated with risks in subsequent pregnancies and later cardiovascular, renal, and metabolic health. →
Maternal and perinatal mortality in pre-eclampsia
Pre-eclampsia can cause fatal maternal complications and remains associated with substantial perinatal mortality. →
Limits of prevention in pre-eclampsia
Early recognition of high-risk factors offers an opportunity to reduce complications of pre-eclampsia. →
Screening approaches for predicting pre-eclampsia
Screening for pre-eclampsia has explored several types of tests to predict disease onset. →
Pre-eclampsia: risk factors, proposed mechanisms and prediction
The passage describes maternal and placental risk factors, proposed disease mechanisms and several approaches to predicting pre-eclampsia. →
Roll over test in pregnancy
The roll over test is a screening test that assesses the diastolic blood pressure response to a change in maternal position. →
Primary preventive measures for pre-eclampsia
The passage describes risk-factor care, antenatal surveillance and exercise as primary preventive measures. →
Secondary prevention and risk assessment of pre-eclampsia
The passage describes preventive interventions in pregnancy and parameters used to assess pre-eclampsia risk. →
Initial treatment objectives in gestational hypertension and pre-eclampsia
Treatment is described as mostly empirical and symptomatic because the etiology of pre-eclampsia remains obscure. →
Maternal and fetal objectives of pre-eclampsia treatment
Treatment objectives include preventing eclampsia and achieving favorable maternal and neonatal outcomes. →
Outpatient monitoring of hypertensive pregnancy without severe features
Women without severe features may receive outpatient care with monitoring in a hospital or day-care center. →
Hospital management of pre-eclampsia with severe features
Pre-eclampsia with severe features requires hospitalization until delivery, with blood pressure stabilization and fetal monitoring. →
Hospital admission, positioning and rest in pre-eclampsia
Hospital admission and rest support continued evaluation and treatment of the patient with pre-eclampsia. →
Diet and caution with diuretics in pre-eclampsia
Dietary guidance accompanies a warning against injudicious diuretic use because of potential harm to the baby. →
Diuretic and antihypertensive use in pre-eclampsia
The passage describes compelling indications for diuretics and indications for antihypertensive treatment in pre-eclampsia. →
Clinical and blood pressure monitoring in pre-eclampsia
A progress chart is used to evaluate the response to treatment in pre-eclampsia. →
Maternal and fetal monitoring in pre-eclampsia
Monitoring follows edema, weight, fluid balance, laboratory findings, and fetal wellbeing; improvement is reflected by favorable clinical and urinary changes. →
Definitive treatment and risk scoring in hypertensive pregnancy
Delivery is the definitive treatment for pre-eclampsia, gestational hypertension and eclampsia. The passage also groups maternal risk factors by gestosis score. →
Factors determining treatment duration in hypertensive disorders of pregnancy
Treatment duration in pre-eclampsia, gestational hypertension, or eclampsia depends on disease severity, pregnancy duration, and maternal and fetal assessment. →
Expectant management of gestational hypertension or pre-eclampsia without severe features
The passage describes continued observation and follow-up for women with gestational hypertension or pre-eclampsia without severe features. →
Recurrence and delivery after observation for hypertension without severe features
Women undergoing expectant management for gestational hypertension or pre-eclampsia without severe features are not considered cured. →
Admission, delivery and monitoring in severe hypertensive disorders of pregnancy
Women with gestational hypertension or pre-eclampsia with severe features require admission; management depends on gestation and maternal and fetal stability. →
Expectant management of pre-eclampsia: delivery triggers and corticosteroids
Continuing pregnancy during expectant management depends on preserving maternal and fetal wellbeing. →
Fetal surveillance and antihypertensive therapy in pre-eclampsia
This portion of the pre-eclampsia management scheme lists fetal surveillance methods and antihypertensive options. →
Management of pre-eclampsia with severe features
The interpretable branches of the management scheme distinguish stable pregnancies before 34 weeks from cases requiring immediate delivery. →
Seizure prophylaxis, blood pressure control and induction in pre-eclampsia
Management of severe pre-eclampsia includes seizure prophylaxis, prevention of maternal cardiovascular complications and induction appropriate to cervical ripeness. →
Pre-eclampsia: anesthesia, labor and postpartum management
The passage describes anesthetic considerations and care during labor and after delivery in women with pre-eclampsia. →
Gestational hypertension and gestational proteinuria
Gestational hypertension describes newly elevated blood pressure without proteinuria in a previously normotensive woman during the specified pregnancy or immediate postpartum period. →
Acute fulminant pre-eclampsia: recognition and immediate management
Acute fulminant pre-eclampsia, also called the pre-eclamptic state, involves acute onset or rapid deterioration with a constant threat of serious complications. →
Delivery decisions in imminent eclampsia
The constant threat of eclampsia makes maternal interest central to decisions about delivery. →
Monitoring in severe pre-eclampsia
The interpretable portions of the monitoring table describe maternal observations and fetal surveillance during care for severe pre-eclampsia. →
Pre-eclampsia: gestational timing and listed clinical abnormalities
The target passage classifies pre-eclampsia by gestational age and lists maternal and fetal abnormalities. The list's specific management heading is not supplied. →
Eclampsia: abrupt onset and preceding features
Eclampsia can begin abruptly, although preceding severe pre-eclampsia is common. →
Definition of eclampsia
The passage defines eclampsia by the neurological complications accompanying pre-eclampsia. →
Eclampsia: incidence and proposed mechanisms of convulsions
Eclampsia is a severe form of pre-eclampsia and may also occur when pre-eclampsia is superimposed on essential hypertension or chronic nephritis. →
Eclampsia: additional seizure mechanisms and timing of fits
The passage continues the proposed causes of cerebral irritation and classifies eclamptic fits by their onset relative to labor and delivery. →
Eclampsia: intercurrent presentation and cerebral findings
Eclampsia may be classified by the timing of convulsions. Cerebral abnormalities and atypical neurological features guide further assessment. →
Clinical features and stages of an eclamptic convulsion
Eclamptic patients usually have premonitory manifestations of acute fulminating preeclampsia. Eclamptic fits are epileptiform and have four stages. →
Status eclampticus, postconvulsive changes and differential diagnosis
Eclampsia must be distinguished from other causes of convulsions or coma during pregnancy or soon afterward. →
Eclampsia: maternal and fetal prognosis
Once convulsions occur, maternal prognosis becomes uncertain. Prognosis includes immediate maternal risks, recovery and subsequent pregnancy outcomes, and fetal survival. →
Prevention of eclampsia and associated complications
The passage identifies measures during preeclampsia that help prevent eclampsia and lists several associated complications. →
Limits of eclampsia prevention and preventive measures
Eclampsia can present atypically, making prediction difficult, and is not always preventable. →
Urgent referral for eclampsia outside hospital
The immediate first-aid priority concerns patients with eclampsia at home or in peripheral health centers. →
Referral and transport of an eclamptic patient
An eclamptic patient requires transfer to a tertiary care center with neonatal and obstetric intensive care management. →
Supportive medical and nursing care in eclampsia
Supportive care in eclampsia focuses on protecting the mother from injury and maintaining breathing. →
Supportive care and monitoring in eclampsia
Medical and nursing management combines seizure and blood pressure control with airway care, close observation and preparation for obstetric management. →
Examination and urinary monitoring after stabilization in eclampsia
Once an eclamptic patient is stabilized, clinical examination and urinary assessment are undertaken. →
Maternal and fetal monitoring after stabilization
Monitoring includes maternal vital signs and urine output, with assessment of labor and fetal heart rate if the patient remains undelivered. →
Fluid balance and infection prevention in pre-eclampsia–eclampsia
Fluid administration requires care because hypovolemia can coexist with tissue fluid overload in pre-eclampsia–eclampsia. →
Objectives of anticonvulsant treatment in eclampsia
Anticonvulsant treatment addresses both ongoing fits and the risk of further convulsions. →
Magnesium sulfate for seizure control in eclampsia
Magnesium sulfate is the drug of choice in the anticonvulsant management of eclampsia. Its effects, intravenous preparation and conditions for repeat dosing are described. →
Magnesium sulfate: therapeutic level, toxicity and contraindications
During magnesium sulfate treatment for eclampsia, serum concentration, renal function and signs of toxicity guide selected monitoring. →
Serum magnesium targets and antidote for cardiac toxicity
The passage describes serum magnesium concentrations during seizure prophylaxis and control, along with a dose consideration and treatment of cardiac toxicity. →
Recurrent eclamptic seizures and magnesium toxicity
The passage continues magnesium sulfate treatment for eclampsia and describes recurrent seizure treatment, toxicity findings, and toxicity management. →
Magnesium sulfate benefits and supportive treatment in eclampsia
The passage describes benefits of magnesium sulfate, treatment of persistent hypertension and pulmonary edema, and measures during a fit. →
Status eclampticus: treatment escalation and intubation
The passage describes treatment for status eclampticus, escalation when treatment fails, and indications for intubation. →
Eclampsia: management of pulmonary and cardiac complications
The passage describes intensive care, infection prevention and treatment of pulmonary edema and heart failure in eclampsia. →
Eclampsia: complication management and obstetric decisions
Management includes treatment of renal and temperature disturbances, intensive multidisciplinary care, and delivery planning after maternal stabilization. →
Eclampsia: delivery decisions and immediate postpartum care
Obstetric management considers seizure control, fetal status, gestational age and obstetric indications for cesarean delivery. →
Initial stabilization before obstetric management of eclampsia
The available flowchart fragment identifies the initial conditions for continuing medical management in eclampsia. →
Clinical assessment during obstetric management of eclampsia
The interpretable portion of this management flowchart identifies assessment of the mother and fetus. →
Postpartum eclampsia care and atypical pre-eclampsia
The passage covers postpartum anticonvulsant treatment, neurologic evaluation, follow-up and presentations that do not meet standard pre-eclampsia criteria. →
Chronic hypertensive disease in pregnancy: definition and risk factors
Chronic hypertensive disease is distinguished by hypertension predating pregnancy or appearing before 20 weeks and persisting beyond 12 weeks after delivery. →
Essential hypertension in pregnancy
Essential hypertension is a common hypertensive state in pregnancy apart from pregnancy-specific hypertensive disorders. →
Essential hypertension in pregnancy: diagnosis, course and complications
Essential hypertension is distinguished from pregnancy-associated hypertension by its earlier onset and persistence after delivery. Pregnancy may alter its course and increase complications. →
Chronic hypertension in pregnancy: fetal risks and management
The passage relates fetal and perinatal risks to the severity of chronic hypertension and outlines blood pressure treatment and obstetric management. →
Chronic renal disease in pregnancy: recognition and prognosis
Chronic renal disease is reported in 0.2% of pregnancies. Urine microscopy and serum biochemical findings can suggest the diagnosis, while prognosis varies with renal impairment. →
Renal disease in pregnancy: risks, management and transplant planning
Renal disease affects pregnancy outcomes, and pregnancy can worsen renal disease. The severity of renal impairment and superimposed pre-eclampsia influence prognosis. →
Fetal surveillance and delivery in maternal renal disease
Pregnancy complicated by renal disease requires close fetal surveillance and individualized delivery planning. →
Pregnancy after renal transplantation
Pregnancy in a renal transplant recipient requires prepregnancy counseling and additional surveillance because maternal complications and graft-related concerns influence care. →
Postpartum care after renal transplantation and overview of pre-eclampsia
The target passage completes postpartum management after renal transplantation and then reviews the defining features and pathological basis of pre-eclampsia. →
Pre-eclampsia and eclampsia: mechanisms, organ effects, and treatment
This passage links endothelial dysfunction and vasospasm to clinical manifestations and summarizes classification and management. →
Eclampsia management and magnesium sulfate monitoring
The passage summarizes prevention, delivery, blood pressure control, and magnesium sulfate use, with additional distinctions concerning gestational hypertension and HELLP syndrome. →
Gestational hypertension and pre-eclampsia: progression, treatment and delivery
Gestational hypertension (GH) can evolve into pre-eclampsia (PE). Disease progression may be rapid, so management depends on severe features and gestational age. →
NEETx
Learn. Practise. Remember.